DISPOSITION OF MITOXANTRONE IN PATIENTS

被引：35

作者：

ALBERTS, DS

PENG, YM

LEIGH, S

DAVIS, TP

WOODWARD, DL

机构：

[1] UNIV ARIZONA,DEPT PHARMACOL,TUCSON,AZ 85724

[2] UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724

[3] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965

来源：

CANCER TREATMENT REVIEWS | 1983年 / 10卷

关键词：

D O I：

10.1016/0305-7372(83)90018-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：23 / 27

页数：5

共 18 条

[1]

AAPRO M, 1982, P AN M AM SOC CLIN, V1, P14

[2] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J].

ALBERTS, DS ;

GRIFFITH, KS ;

GOODMAN, GE ;

HERMAN, TS ;

MURRAY, E .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :11-15

[3]

ESTEY EH, 1982, P AM ASSOC CANC RES, V23, P113

[4]

NEIDHART J, 1981, P AM ASSOC CANC RES, V22, P363

[5]

NEIDHART JA, 1982, P AN M AM SOC CLIN, V1, P86

[6] AN HPLC METHOD FOR THE QUANTITATIVE-DETERMINATION OF 1,4-DIHYDROXY-5,8 BIS [[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]9,10-ANTHRACENEDIONE (DHAQ, LEDERLE LABS CL232315, NCS 301739) IN SERUM [J].

OSTROY, F ;

GAMS, RA .

JOURNAL OF LIQUID CHROMATOGRAPHY, 1980, 3 (05) :637-644

[7]

PENG YM, 1981, LIFE SCI, V29, P361

[8]

PENG YM, 1983, J CHROMATOGR BIOMED, V233, P235

[9] CLINICAL ANALYSIS FOR THE ANTI-NEOPLASTIC AGENT 1,4-DIHYDROXY-5,8-BIS((2-[(2-HYDROXYETHYL)AMINO]ETHYL)-AMINO) 9,10-ANTHRACENEDIONE DIHYDROCHLORIDE (NSC 301739) IN PLASMA - APPLICATION OF TEMPERATURE CONTROL TO PROVIDE SELECTIVITY IN PAIRED-ION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

REYNOLDS, DL ;

STERNSON, LA ;

REPTA, AJ .

JOURNAL OF CHROMATOGRAPHY, 1981, 222 (02) :225-240

[10] QUANTITATION OF DIFFERENTIAL SENSITIVITY OF HUMAN-TUMOR STEM-CELLS TO ANTI-CANCER DRUGS [J].

SALMON, SE ;

HAMBURGER, AW ;

SOEHNLEN, B ;

DURIE, BGM ;

ALBERTS, DS ;

MOON, TE .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (24) :1321-1327

← 1 2 →